The female mortality from cvd, cancer, diabetes or crd between exact ages 30 and 70 in Syria currently stands at 17.8%, marking a decrease of 0.3% (-1.7%) compared to 2020.
Female mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 in Syria
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2021
Points:
13,975
Measure:
%
More indicators for Syria
Out-of-pocket expenditure PPP per capita
intl dollar207
-intl dollar36
(2022)
Newborns protected against tetanus
88%
-2%
(2023)
Female wasting in children
10.5%
+1.4%
(2010)
Birth registration
96%
(2006)
Female prevalence of HIV
0.1%
0%
(2022)
Contraceptive modern method prevalence
37.5%
-8.8%
(2009)
Syria Female CVD, cancer, diabetes or CRD between 2000 and 2021
| Period | Value | Change |
|---|---|---|
| 2021 | 17.8% | -0.3% |
| 2020 | 18.1% | -0.2% |
| 2019 | 18.3% | -0.2% |
| 2018 | 18.5% | 0% |
| 2017 | 18.5% | 0% |
| 2016 | 18.5% | -0.1% |
| 2015 | 18.6% | +0.1% |
| 2014 | 18.5% | +0.1% |
| 2013 | 18.4% | +0.1% |
| 2012 | 18.3% | +0.1% |
| 2011 | 18.2% | -0.1% |
| 2010 | 18.3% | -0.1% |
| 2009 | 18.4% | -0.4% |
| 2008 | 18.8% | 0% |
| 2007 | 18.8% | -0.5% |
| 2006 | 19.3% | -0.4% |
| 2005 | 19.7% | -0.8% |
| 2004 | 20.5% | -0.1% |
| 2003 | 20.6% | -1.2% |
| 2002 | 21.8% | -0.2% |
| 2001 | 22% | -1.5% |
| 2000 | 23.5% |